The efficacy of clinicopathological and imaging features in differentiating benign from malignant parotid micro- and minitumors: a retrospective analysis

Abstract

ObjectiveTo compare clinicopathological and imaging and features of micro- and minitumors of the parotid gland and provide a reference for preoperative prediction of benign vs. malignant status. Study DesignPatients with parotid gland tumors treated surgically were selected. Relevant clinicopathological and imaging data were collected for patients with maximum tumor diameters ≤ 20 mm on preoperative computed tomography (CT). The lesions were divided into two groups, microtumors and minitumors, based on maximum tumor diameter. CT imaging features of benign and malignant tumors were compared through binary logistic regression analysis. ResultsMicrotumors and minitumors were categorized by maximum diameters < 10 mm (n = 74) and 10-20 mm (n = 611), respectively. Benign and malignant minitumors exhibited significant differences in boundary, tumor density, margin morphology, spiculation margin, and CT values in the plain and arterial phase (P < 0.05), resembling those found in typical malignant parotid gland tumors. However, no significant differences were observed between benign and malignant microtumors. Logistic regression analysis identified boundary, margin morphology, and spiculation margin as independent predictors of malignancy. The prediction model excelled in identifying benign lesions but was less successful in identifying malignancies. ConclusionParotid gland minitumors had imaging features similar to typical larger malignant tumors. Active exclusion of the malignant risk and early surgical treatment is recommended for these tumors. Statement of Clinical RelevanceThis study analyzed the clinicopathological and imaging features of micro- and minitumors of the parotid gland to provide a reference for preoperative prediction and treatment. Active exclusion of malignant risk and early surgical treatment is recommended for small parotid tumors.